Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial
Authors:
- 17 April 2020
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 223 (4) , 551.e1-551.e7
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 12 references indexed in Scilit:
- Treatment Decisions at the Time of Miscarriage DiagnosisObstetrics & Gynecology, 2016
- Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and ElaborationAnnals of Internal Medicine, 2015
- Nicotine treatment prolongs gestation and inhibits cervical ripening in pregnant ratsAmerican Journal of Obstetrics and Gynecology, 2014
- Estimated pregnancy rates and rates of pregnancy outcomes for the United States, 1990-2008.2012
- Receiver-Operating Characteristic Analysis for Evaluating Diagnostic Tests and Predictive ModelsCirculation, 2007
- Medical treatment for early fetal death (less than 24 weeks)Cochrane Database of Systematic Reviews, 2006
- Studies on uterine contractility following mifepristone and various routes of misoprostolContraception, 2006
- Factors Related to Successful Misoprostol Treatment for Early Pregnancy FailureObstetrics & Gynecology, 2006
- A Comparison of Medical Management with Misoprostol and Surgical Management for Early Pregnancy FailureNew England Journal of Medicine, 2005
- The maternal and fetal physiologic effects of nicotineSeminars in Perinatology, 1996